COVID-19 collection: Insights by sector has been saved
Insights
COVID-19 collection: Insights by sector
Explore sector specific COVID-19 (novel coronavirus) insights
Understanding COVID-19’s impact on the automotive sector
Guidance for automotive executives
How the Automotive Industry is acting to mitigate risk during the epidemic
Deloitte China provides insights and mitigating actions for the automotive industry in response to the impact of COVID-19.
Understanding COVID-19’s impact on the civil government sector
Guidance for civil government leaders
Understanding COVID-19's impact on transport organizations
Guidance for transportation leaders
COVID-19: Impact on non-food consumer products companies
Guidance for Consumer Products executives leading non-food companies
COVID-19: Impact on food and beverage consumer products companies
Guidance for Consumer Products executives leading food and beverage companies
Maintaining customer loyalty and trust during times of uncertainty
As the world joins forces to contain the current COVID-19 crisis, businesses are concerned with the impact that events may have on the relationship with their customers. Explore ways to maintain customer loyalty and trust in this report.
People, technology, and the path to organizational resilience
In this latest piece, Deloitte Canada examines the responsibility that IT leaders have to not only lead their function through the current pandemic, but also to support the entire enterprise, especially since technology has become increasingly woven into the fabric of business.
COVID-19: Managing supply chain risk and disruption
This piece from Deloitte Canada highlights short-term actions companies can take to respond to business disruption and supply chain challenges from the global spread of COVID-19 ─ and looks ahead to the longer-term solution of digital supply networks.
COVID-19: Navigating volatility and distress
This piece from Deloitte in the UK provides guidance for companies experiencing significant operational disruption due to public policy measures put in place to contain the spread of COVID-19.
Deloitte Travel Risk eMap
Deloitte has designed a Travel Risk eMap by using advanced data capture technology to collect and summarize the latest news from authoritative websites. This visual map can help you quickly understand global trends and the latest travel restrictions in destinations around the world.
Preparing for the new coronavirus outbreak
It is important that organizations are proactive and prepared for COVID-19, while remaining pragmatic, as the situation continues to quickly evolve. This article outlines practical steps for pandemic preparedness.
COVID-19’s impact on the defense, security, and justice sector
Guidance for defense, security, and justice leaders
Understanding COVID-19’s impact on the real estate sector
Guidance for real estate executives
COVID-19 considerations for the UK real estate sector
Guidance for real estate executives in the United Kingdom
COVID-19 potential implications for the banking and capital markets sector
Learn what questions banking and capital markets leaders should be asking themselves right now and what actions should be considered in the face of COVID-19.
COVID-19 and the investment management industry
Without fresh information, processed at the speed at which markets are moving, investment professionals could be operating suboptimally—at a critical time.
The impact of COVID-19 on China's pharmaceuticals industry as it responds, recovers, and thrives.
With the breakout of COVID-19, Deloitte China's Life Sciences & Health Care Industry team initiated a survey to understand the virus' impact on China pharmaceutical industry and measure the longer-term impact this could eventually have on their business model and operating processes.
Six predictions for China's pharma & health care sector
What are some potential impacts of COVID-19 on China's health care sector? Discover six predictions in this piece from Deloitte China.
COVID-19: A black swan event for the semiconductor industry?
Deloitte leaders discuss the impact COVID-19 presents to the semiconductor industry’s supply chains and global growth. It includes suggestions for managing near-term disruptions and maintaining business continuity while presenting an opportunity to transform the global supply chain model to create a more resilient future.
The impact of COVID-19 on China's pharmaceuticals industry as it responds, recovers, and thrives.
With the breakout of COVID-19, Deloitte China's Life Sciences & Health Care Industry team initiated a survey to understand the virus' impact on China pharmaceutical industry and measure the longer-term impact this could eventually have on their business model and operating processes.
